20 results
8-K
EX-99.1
QLGN
Qualigen Therapeutics Inc
1 Aug 23
Regulation FD Disclosure
8:35am
and demonstrates leadership in G4-targeting therapies for areas of high unmet need in oncology
CARLSBAD, Calif., August 1st, 2023 (GLOBE NEWSWIRE) – Qualigen
8-K
pr1 dz8k3zejw90
17 May 21
Amendments to Articles of Incorporation or Bylaws
5:21pm
8-K
khyh0re63 5y995
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-99.1
coszs
29 May 18
Ritter Pharmaceuticals Announces Appointment of John W. Beck as Chief Financial Officer
6:11am
10-K
7829ha emcnhyi
21 Mar 16
Annual report
12:00am
DRS
2tg7whg1 vr
29 Jan 15
Draft registration statement
12:00am
- Prev
- 1
- Next